CCL2 and cancer: The p65/ZEB1 pathway that regulates the transcription of PD-L1, as well as TLR9, IFN-γ, MCP-1 (monocyte chemoattractant protein-1), and GM-CSF (granulocyte-macrophage colony-stimulating factor) in cancer cells, is activated by MUC1 [112].